comparegroups updated: version 2.0
|
|
- Isaac Stevenson
- 5 years ago
- Views:
Transcription
1 comparegroups updated: version 2.0 Isaac Subirana & Joan Vila & Héctor Sanz & Judith Peñafiel & Gavin Lucas & David Giménez & & & RICAD Research on Inflammatory and Cardiovascular Disorders Program IMIM-Parc de Salut Mar, Barcelona userr! Albacete, July 10-12, 2013 Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
2 Introduction Motivation Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, Gómez-Gracia E, Ruiz-Gutiérrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pintó X, Basora J, Muñoz MA, Sorĺı JV, Martínez JA, Martínez-González MA; PREDIMED Study Investigators (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine 368(14): Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
3 Introduction Package overview comparegroups package is meant to facilitate the user to create bivariate tables in an easy and rapid way. It has a lot of parameters to change different options: decimals, reference category, report means or medians, etc. Its code is structured in classes and methods in order to make the syntax code easier (formula, update, subset,...). It is simple and short to change deafault options. A GUI has been implemented for non familiarized R users.... WUI is under development. comparegroups package (version 1.4) is available on CRAN. The present version, comparegroups 2.0 will be submitted to CRAN soon. Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
4 Introduction Other existing R packages Already existent many functions to display descriptives: summaryby [doby], stat.desc [pastecs], ctab [catspec], stat.table [Epi], tablenominal, tabledate, tablecontinuous [reporttools], summary.formula [Hmisc],... Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
5 Introduction Other existing R packages But... Some of them too much specific: only categorical or only continuous Don t mix categorical, normal (mean-sd), non-normal (quantiles) Not very intuitive to customize tables No GUI s, Difficult to add HR/OR, to deal with time-to-event variables,..., Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
6 Introduction Improvements in 2.0 version Missingness test, Improvements in current version Analysis of genetic data (SNPs), Export tables to PDF, Generation of exhaustive report to PDF file, Create plots in pdf, bmp, jpeg, png or tiff. More formats in reporting statistics: mean ± SD,..., More detailed vignette with new data set (PREDIMED), GUI improved, WUI interface to use it from a remote server, web site to recieve feed back, publish package news, etc. Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
7 How to use it 1 By syntax (full functionallity) 2 By GUI (tcltk) 3 By WUI (no R installation required) under development Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
8 Classes and methods structure functions classes methods displaying modifying print update summary subset [ plot rbind comparegroups comparegroups comparesnps* update subset rbind cbind plot createtable createtable missingtable* print summary already implemented export2: latex, csv, html, pdf report new improved Step 1: Computations Step 2: Construction Step 3: Exportation Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
9 Results On R console Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
10 Results LaTeX format MALE FEMALE No event Event No event Event HR N=2528 N=151 N=3544 N=101 Epidemiological: Age 66.0± ± [1.03;1.08] 67.6± ± [1.07;1.14] Body mass index 29.3± ± [0.97;1.06] 30.5± ± [0.94;1.04] Waist circumference 103± ± [0.99;1.02] 98.3± ± [1.00;1.03] Waist-to-height ratio 0.62± ± [0.85;205] 0.64± ± [0.89;204] History: Smoking: Never 27.0% 16.6% Ref. 87.4% 88.1% Ref. Current 24.8% 26.5% 1.63 [0.99;2.69] 5.14% 8.91% 1.94 [0.97;3.84] Former 48.2% 57.0% 1.92 [1.23;3.00] 7.51% 2.97% 0.43 [0.14;1.35] Hypertension 77.7% 79.5% 1.20 [0.81;1.79] 86.4% 89.1% 1.31 [0.70;2.46] Type-2 diabetes 52.0% 64.2% 1.59 [1.14;2.22] 43.1% 63.4% 2.12 [1.41;3.18] Dyslipidemia 66.6% 58.9% 0.81 [0.58;1.11] 77.4% 61.4% 0.52 [0.35;0.78] Family history 17.4% 14.6% 0.89 [0.57;1.41] 26.5% 28.7% 1.18 [0.77;1.82] Mediterranean diet: Intervention group: Control 29.8% 38.4% Ref. 33.6% 38.6% Ref. MedDiet + Nuts 36.7% 27.2% 0.54 [0.36;0.80] 31.1% 28.7% 0.78 [0.48;1.26] MedDiet + VOO 33.5% 34.4% 0.71 [0.49;1.03] 35.3% 32.7% 0.69 [0.43;1.10] MeDiet Adherence score 9.00 [8.00;10.0] 8.00 [7.00;10.0] 0.87 [0.81;0.94] 9.00 [7.00;10.0] 8.00 [7.00;9.00] 0.88 [0.80;0.97] HR Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
11 Results On HTML format Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
12 Plots univariate Normality plots of 'Body mass index' Barplot of 'Smoking' Histogram mean= 30.0 SD= 3.82 Normal Q Q Plot Boxplot desv. Theoretical Quantiles Sample Quantiles Standard deviation from normality Freq Never Current Former K M survival of 'tevent' survival time Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
13 Plots bivariate Boxplot of 'Body mass index' by 'Intervention group' Barplot of 'Smoking' by 'Intervention group' Freq Never Current Former Control MedDiet + Nuts MedDiet + VOO Control MedDiet + Nuts MedDiet + VOO K M survival of 'tevent' by 'Smoking' survival Never Current Former time Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
14 By syntax Select variables, type,... > res <- comparegroups(tevent ~.-toevent-event, + data = predimed, + method = c(p14 = 2), + ref.no = 'no') > res Summary of results by groups of 'tevent' var N p.value method selection 1 Intervention group ** categorical ALL 2 Sex 6324 <0.001** categorical ALL 3 Age 6324 <0.001** continuous normal ALL 4 Smoking 6324 <0.001** categorical ALL 5 Body mass index continuous normal ALL 6 Waist circumference ** continuous normal ALL 7 Waist-to-height ratio * continuous normal ALL 8 Hypertension categorical ALL 9 Type-2 diabetes 6324 <0.001** categorical ALL 10 Dyslipidemia 6324 <0.001** categorical ALL 11 Family history of premature CHD categorical ALL 12 Hormone-replacement therapy categorical ALL 13 MeDiet Adherence score 6324 <0.001** continuous non-normal ALL Signif. codes: 0 '**' 0.05 '*' 0.1 ' ' 1 Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
15 > restab <- createtable(res) By syntax Building the table No event Event N=6072 N=252 p.overall Intervention group: Control 1945 (32.0%) 97 (38.5%) MedDiet + Nuts 2030 (33.4%) 70 (27.8%) MedDiet + VOO 2097 (34.5%) 85 (33.7%) Sex: <0.001 Male 2528 (41.6%) 151 (59.9%) Female 3544 (58.4%) 101 (40.1%) Age 66.9 (6.14) 69.4 (6.65) <0.001 Smoking: <0.001 Never 3778 (62.2%) 114 (45.2%) Current 809 (13.3%) 49 (19.4%) Former 1485 (24.5%) 89 (35.3%) Body mass index 30.0 (3.81) 29.8 (3.92) Waist circumference 100 (10.6) 102 (10.6) Waist-to-height ratio 0.63 (0.07) 0.63 (0.07) Hypertension: No 1047 (17.2%) 42 (16.7%) Yes 5025 (82.8%) 210 (83.3%) Type-2 diabetes: <0.001 No 3231 (53.2%) 91 (36.1%) Yes 2841 (46.8%) 161 (63.9%) Dyslipidemia: <0.001 No 1645 (27.1%) 101 (40.1%) Yes 4427 (72.9%) 151 (59.9%) Family history of premature CHD: No 4694 (77.3%) 201 (79.8%) Yes 1378 (22.7%) 51 (20.2%) Hormone-replacement therapy: No 5341 (98.2%) 223 (99.6%) Yes 96 (1.77%) 1 (0.45%) MeDiet Adherence score 9.00 [7.00;10.0] 8.00 [7.00;10.0] <0.001 Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
16 By syntax Costumazing the table > restab <- update(restab, hide.no="no", hide=c(sex='female')) No event Event N=6072 N=252 p.overall Intervention group: Control 1945 (32.0%) 97 (38.5%) MedDiet + Nuts 2030 (33.4%) 70 (27.8%) MedDiet + VOO 2097 (34.5%) 85 (33.7%) Sex: Male 2528 (41.6%) 151 (59.9%) <0.001 Age 66.9 (6.14) 69.4 (6.65) <0.001 Smoking: <0.001 Never 3778 (62.2%) 114 (45.2%) Current 809 (13.3%) 49 (19.4%) Former 1485 (24.5%) 89 (35.3%) Body mass index 30.0 (3.81) 29.8 (3.92) Waist circumference 100 (10.6) 102 (10.6) Waist-to-height ratio 0.63 (0.07) 0.63 (0.07) Hypertension 5025 (82.8%) 210 (83.3%) Type-2 diabetes 2841 (46.8%) 161 (63.9%) <0.001 Dyslipidemia 4427 (72.9%) 151 (59.9%) <0.001 Family history of premature CHD 1378 (22.7%) 51 (20.2%) Hormone-replacement therapy 96 (1.77%) 1 (0.45%) MeDiet Adherence score 9.00 [7.00;10.0] 8.00 [7.00;10.0] <0.001 Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
17 By syntax Costumazing the table > restab <- update(restab, type = 1) No event Event N=6072 N=252 p.overall Intervention group: Control 32.0% 38.5% MedDiet + Nuts 33.4% 27.8% MedDiet + VOO 34.5% 33.7% Sex: Male 41.6% 59.9% <0.001 Age 66.9 (6.14) 69.4 (6.65) <0.001 Smoking: <0.001 Never 62.2% 45.2% Current 13.3% 19.4% Former 24.5% 35.3% Body mass index 30.0 (3.81) 29.8 (3.92) Waist circumference 100 (10.6) 102 (10.6) Waist-to-height ratio 0.63 (0.07) 0.63 (0.07) Hypertension 82.8% 83.3% Type-2 diabetes 46.8% 63.9% <0.001 Dyslipidemia 72.9% 59.9% <0.001 Family history of premature CHD 22.7% 20.2% Hormone-replacement therapy 1.77% 0.45% MeDiet Adherence score 9.00 [7.00;10.0] 8.00 [7.00;10.0] <0.001 Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
18 By syntax Costumazing the table > restab <- update(restab, show.ratio=true, show.p.overall=false) No event Event N=6072 N=252 HR p.ratio Intervention group: Control 32.0% 38.5% Ref. Ref. MedDiet + Nuts 33.4% 27.8% 0.66 [0.48;0.89] MedDiet + VOO 34.5% 33.7% 0.70 [0.53;0.94] Sex: Male 41.6% 59.9% Ref. Ref. Age 66.9 (6.14) 69.4 (6.65) 1.06 [1.04;1.09] <0.001 Smoking: Never 62.2% 45.2% Ref. Ref. Current 13.3% 19.4% 1.96 [1.40;2.74] <0.001 Former 24.5% 35.3% 2.02 [1.53;2.67] <0.001 Body mass index 30.0 (3.81) 29.8 (3.92) 0.99 [0.96;1.02] Waist circumference 100 (10.6) 102 (10.6) 1.02 [1.01;1.03] Waist-to-height ratio 0.63 (0.07) 0.63 (0.07) 5.27 [0.83;33.6] Hypertension 82.8% 83.3% 1.10 [0.79;1.53] Type-2 diabetes 46.8% 63.9% 1.88 [1.46;2.44] <0.001 Dyslipidemia 72.9% 59.9% 0.62 [0.49;0.80] <0.001 Family history of premature CHD 22.7% 20.2% 0.93 [0.68;1.26] Hormone-replacement therapy 1.77% 0.45% 0.29 [0.04;2.10] MeDiet Adherence score 9.00 [7.00;10.0] 8.00 [7.00;10.0] 0.88 [0.83;0.94] <0.001 Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
19 By syntax Costumazing the table > restab <- update(restab, show.descr=false) HR p.ratio Intervention group: Control Ref. Ref. MedDiet + Nuts 0.66 [0.48;0.89] MedDiet + VOO 0.70 [0.53;0.94] Sex: Male Ref. Ref. Age 1.06 [1.04;1.09] <0.001 Smoking: Never Ref. Ref. Current 1.96 [1.40;2.74] <0.001 Former 2.02 [1.53;2.67] <0.001 Body mass index 0.99 [0.96;1.02] Waist circumference 1.02 [1.01;1.03] Waist-to-height ratio 5.27 [0.83;33.6] Hypertension 1.10 [0.79;1.53] Type-2 diabetes 1.88 [1.46;2.44] <0.001 Dyslipidemia 0.62 [0.49;0.80] <0.001 Family history of premature CHD 0.93 [0.68;1.26] Hormone-replacement therapy 0.29 [0.04;2.10] MeDiet Adherence score 0.88 [0.83;0.94] <0.001 Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
20 By syntax Costumazing the table > males<-update(restab,x=update(res,.~.-sex,subset=sex=='male'),hide=na) > females<-update(restab,x=update(res,.~.-sex,subset=sex=='female'),hide=na) > tabcomb<-cbind("males"=males,"females"=females) Males Females HR p.ratio HR p.ratio Intervention group: Control Ref. Ref. Ref. Ref. MedDiet + Nuts 0.54 [0.36;0.80] [0.48;1.26] MedDiet + VOO 0.71 [0.49;1.03] [0.43;1.10] Age 1.06 [1.03;1.08] < [1.07;1.14] <0.001 Smoking: Never Ref. Ref. Ref. Ref. Current 1.63 [0.99;2.69] [0.97;3.84] Former 1.92 [1.23;3.00] [0.14;1.35] Body mass index 1.01 [0.97;1.06] [0.94;1.04] Waist circumference 1.01 [0.99;1.02] [1.00;1.03] Waist-to-height ratio 13.2 [0.85;205] [0.89;204] Hypertension 1.20 [0.81;1.79] [0.70;2.46] Type-2 diabetes 1.59 [1.14;2.22] [1.41;3.18] <0.001 Dyslipidemia 0.81 [0.58;1.11] [0.35;0.78] Family history of premature CHD 0.89 [0.57;1.41] [0.77;1.82] Hormone-replacement therapy Ref. Ref [0.06;2.98] MeDiet Adherence score 0.87 [0.81;0.94] [0.80;0.97] Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
21 By syntax Methods/functions on tables > varinfo(restab) --- Analyzed variable names ---- Orig varname Shown varname 1 tevent tevent 2 group Intervention group 3 sex Sex 4 age Age 5 smoke Smoking 6 bmi Body mass index 7 waist Waist circumference 8 wth Waist-to-height ratio 9 htn Hypertension 10 diab Type-2 diabetes 11 hyperchol Dyslipidemia 12 famhist Family history of premature CHD 13 hormo Hormone-replacement therapy 14 p14 MeDiet Adherence score Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
22 By syntax Methods/functions on tables > summary(restab) ---Available data---- [ALL] No event Event method select Fact OR/HR Intervention group categorical ALL -- Sex categorical ALL -- Age continuous-normal ALL 1 Smoking categorical ALL -- Body mass index continuous-normal ALL 1 Waist circumference continuous-normal ALL 1 Waist-to-height ratio continuous-normal ALL 1 Hypertension categorical ALL -- Type-2 diabetes categorical ALL -- Dyslipidemia categorical ALL -- Family history of premature CHD categorical ALL -- Hormone-replacement therapy categorical ALL -- MeDiet Adherence score continuous-non-normal ALL 1 Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
23 By syntax Methods/functions on tables > restab[1:5] Summary descriptives table by 'tevent' HR p.ratio Intervention group: Control Ref. Ref. MedDiet + Nuts 0.66 [0.48;0.89] MedDiet + VOO 0.70 [0.53;0.94] Sex: Male Ref. Ref. Age 1.06 [1.04;1.09] <0.001 Smoking: Never Ref. Ref. Current 1.96 [1.40;2.74] <0.001 Former 2.02 [1.53;2.67] <0.001 Body mass index 0.99 [0.96;1.02] Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
24 REGICOR data By syntax Missingness N=431 N=786 N=1077 p.overall Age 54.1 (11.7) 54.3 (11.2) 55.3 (10.6) Sex: Male 206 (47.8%) 390 (49.6%) 505 (46.9%) Female 225 (52.2%) 396 (50.4%) 572 (53.1%) Smoking status: <0.001 Never smoker 234 (56.4%) 414 (54.6%) 553 (52.2%) Current or former < 1y 109 (26.3%) 267 (35.2%) 217 (20.5%) Former 1y 72 (17.3%) 77 (10.2%) 290 (27.4%) Systolic blood pressure 133 (19.2) 133 (21.3) 129 (19.8) <0.001 Diastolic blood pressure 77.0 (10.5) 80.8 (10.3) 79.9 (10.6) <0.001 History of hypertension 111 (25.8%) 233 (29.6%) 379 (35.5%) <0.001 Hypertension treatment 71 (16.5%) 127 (16.2%) 230 (22.2%) Total cholesterol 225 (43.1) 224 (44.4) 213 (45.9) <0.001 HDL cholesterol 51.9 (14.5) 52.3 (15.6) 53.2 (14.2) Triglycerides 114 (74.4) 114 (70.7) 117 (76.0) LDL cholesterol 152 (38.4) 149 (38.6) 136 (39.7) <0.001 History of hyperchol. 97 (22.5%) 256 (33.2%) 356 (33.2%) <0.001 Cholesterol treatment 28 (6.50%) 68 (8.80%) 132 (12.8%) <0.001 Height (cm) 163 (9.21) 162 (9.39) 163 (9.05) Weight (Kg) 72.3 (12.6) 73.8 (14.0) 73.6 (13.9) Body mass index 27.0 (4.15) 28.1 (4.62) 27.6 (4.63) <0.001 Physical activity (Kcal/week) 491 (419) 422 (377) 351 (378) <0.001 Physical component 49.3 (8.08) 49.0 (9.63) 50.1 (8.91) Mental component 49.2 (11.3) 48.9 (11.0) 46.9 (10.8) <0.001 Cardiovascular event 10 (2.51%) 35 (4.72%) 47 (4.59%) Days to cardiovascular event or end of follow-up 1784 (1101) 1686 (1080) 1793 (1072) Overall death 18 (4.65%) 81 (11.0%) 74 (7.23%) <0.001 Days to overall death or end of follow-up 1713 (1042) 1674 (1050) 1758 (1055) Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
25 By syntax Missingness Missing table > mistab<-missingtable(regtab) N=431 N=786 N=1077 p.overall Age 0 (0.00%) 0 (0.00%) 0 (0.00%) Sex 0 (0.00%) 0 (0.00%) 0 (0.00%) Smoking status 16 (3.71%) 28 (3.56%) 17 (1.58%) Systolic blood pressure 3 (0.70%) 11 (1.40%) 0 (0.00%) <0.001 Diastolic blood pressure 3 (0.70%) 11 (1.40%) 0 (0.00%) <0.001 History of hypertension 0 (0.00%) 0 (0.00%) 8 (0.74%) Hypertension treatment 0 (0.00%) 0 (0.00%) 43 (3.99%) <0.001 Total cholesterol 28 (6.50%) 71 (9.03%) 2 (0.19%) <0.001 HDL cholesterol 30 (6.96%) 38 (4.83%) 1 (0.09%) <0.001 Triglycerides 28 (6.50%) 34 (4.33%) 1 (0.09%) <0.001 LDL cholesterol 43 (9.98%) 98 (12.5%) 27 (2.51%) <0.001 History of hyperchol. 0 (0.00%) 15 (1.91%) 6 (0.56%) Cholesterol treatment 0 (0.00%) 13 (1.65%) 42 (3.90%) <0.001 Height (cm) 8 (1.86%) 15 (1.91%) 12 (1.11%) Weight (Kg) 8 (1.86%) 15 (1.91%) 12 (1.11%) Body mass index 8 (1.86%) 15 (1.91%) 12 (1.11%) Physical activity (Kcal/week) 64 (14.8%) 22 (2.80%) 2 (0.19%) <0.001 Physical component 34 (7.89%) 123 (15.6%) 83 (7.71%) <0.001 Mental component 34 (7.89%) 123 (15.6%) 83 (7.71%) <0.001 Cardiovascular event 33 (7.66%) 45 (5.73%) 53 (4.92%) Days to cardiovascular event or end of follow-up 33 (7.66%) 45 (5.73%) 53 (4.92%) Overall death 44 (10.2%) 48 (6.11%) 54 (5.01%) Days to overall death or end of follow-up 44 (10.2%) 48 (6.11%) 54 (5.01%) Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
26 By syntax Missingness Include NA as new category: > regtab2<-update(regtab,x=update(res,include.miss=true)) N=431 N=786 N=1077 p.overall Age 54.1 (11.7) 54.3 (11.2) 55.3 (10.6) Sex: Male 206 (47.8%) 390 (49.6%) 505 (46.9%) Female 225 (52.2%) 396 (50.4%) 572 (53.1%) Smoking status: <0.001 Never smoker 234 (54.3%) 414 (52.7%) 553 (51.3%) Current or former < 1y 109 (25.3%) 267 (34.0%) 217 (20.1%) Former 1y 72 (16.7%) 77 (9.80%) 290 (26.9%) <Missing> 16 (3.71%) 28 (3.56%) 17 (1.58%) Systolic blood pressure 133 (19.2) 133 (21.3) 129 (19.8) <0.001 Diastolic blood pressure 77.0 (10.5) 80.8 (10.3) 79.9 (10.6) <0.001 History of hypertension: <0.001 Yes 111 (25.8%) 233 (29.6%) 379 (35.2%) No 320 (74.2%) 553 (70.4%) 690 (64.1%) <Missing> 0 (0.00%) 0 (0.00%) 8 (0.74%) Hypertension treatment: <0.001 No 360 (83.5%) 659 (83.8%) 804 (74.7%) Yes 71 (16.5%) 127 (16.2%) 230 (21.4%) <Missing> 0 (0.00%) 0 (0.00%) 43 (3.99%) Total cholesterol 225 (43.1) 224 (44.4) 213 (45.9) <0.001 HDL cholesterol 51.9 (14.5) 52.3 (15.6) 53.2 (14.2) Triglycerides 114 (74.4) 114 (70.7) 117 (76.0) LDL cholesterol 152 (38.4) 149 (38.6) 136 (39.7) <0.001 History of hyperchol.: <0.001 Yes 97 (22.5%) 256 (32.6%) 356 (33.1%) No 334 (77.5%) 515 (65.5%) 715 (66.4%) <Missing> 0 (0.00%) 15 (1.91%) 6 (0.56%) Cholesterol treatment: <0.001 No 403 (93.5%) 705 (89.7%) 903 (83.8%) Yes Isaac Subirana & Joan Vila (RICAD) 28 (6.50%) 68 (8.65%) comparegroups updated: version (12.3%) July 10-12, / 36
27 By syntax Exporting the table to L A TEX > export2latex(restab,"table1") to ASCII (csv) > export2csv(restab,"table1") to HTML > export2html(restab,"table1") to PDF > export2pdf(restab,"table1") Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
28 By syntax Summary of genetic data > comparesnps( ~ snp10001+snp10002+snp10003+snp snp10005+snp10006+snp10007+snp10008, SNPs) *********** Summary of genetic data (SNPs) *********** SNP Ntyped MAF Genotypes Genotypes.p HWE.p ===================================================== snp % TT TC CC snp % CC CA AA snp % GG snp % GG snp % GG GA AA snp % AA snp % CC snp % CC CG GG Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
29 GUI > cgroupsgui() Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
30 Web User Interface Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
31 Web User Interface Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
32 Web User Interface Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
33 Web User Interface Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
34 Web site comparegroups web site Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
35 Future works Future works Develop WUI and website Implement other tabular environments when exporting to L A TEX. Export to Word (explore R2wd package).... Suggestions Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
36 THANK YOU! MUCHAS GRACIAS! MOLTES GRÀCIES! Don t hesitate to contact us: Isaac Subirana < isubirana@imim.es > Joan Vila < jvila@imim.es > Isaac Subirana & Joan Vila (RICAD) comparegroups updated: version 2.0 July 10-12, / 36
New evidences of the effects of the Mediterranean diet in the prevention of cardiovascular disease
THE PREDIMED STUDY New evidences of the effects of the Mediterranean diet in the prevention of cardiovascular disease Dr. María Isabel Covas Cardiovascular Risk and Nutrition Research Group The REGICOR
More informationMA Martínez-González.
MA Martínez-González Coordinador RD 06/0045 PREDIMED (Alimentación saludable en la prevención primaria de enfermedades crónicas) www.unav.es/preventiva Estrategia Estructura organizativa Trabajo en red
More informationEffects of polyphenol intake on cardiovascular risk markers
Effects of polyphenol intake on cardiovascular risk markers OMICS: Advances, Applications and Translation in Nutrition and Epidemiology Boston, May 30, 2017 Rosa M. Lamuela-Raventós Departament of Nutrition,
More informationFigure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution
Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution of A: total cholesterol (TC); B: low-density lipoprotein
More informationLa Dieta Mediterrània en la DM2. L estudi Predimed
Dr. María-Isabel Covas Cardiovascular Risk and Nutrition Research Group The REGICOR Study Group IMIM Hospital del Mar Research Institut Barcelona Spain CIBER de Fisiopatología de la Obesidad y Nutrición
More informationTable S1. Characteristics associated with frequency of nut consumption (full entire sample; Nn=4,416).
Table S1. Characteristics associated with frequency of nut (full entire sample; Nn=4,416). Daily nut Nn= 212 Weekly nut Nn= 487 Monthly nut Nn= 1,276 Infrequent or never nut Nn= 2,441 Sex; n (%) men 52
More informationKnow Your Number Aggregate Report Single Analysis Compared to National Averages
Know Your Number Aggregate Report Single Analysis Compared to National s Client: Study Population: 2242 Population: 3,000 Date Range: 04/20/07-08/08/07 Version of Report: V6.2 Page 2 Study Population Demographics
More informationSupplementary Online Content
Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.
More informationNORTH SOUTH UNIVERSITY TUTORIAL 1
NORTH SOUTH UNIVERSITY TUTORIAL 1 REVIEW FROM BIOSTATISTICS I AHMED HOSSAIN,PhD Data Management and Analysis AHMED HOSSAIN,PhD - Data Management and Analysis 1 DATA TYPES/ MEASUREMENT SCALES Categorical:
More informationPROOF. (not for distribution)
THELANCETDE-D-16-00306R1 S2213-8587(16)30085-7 Embargo: June 6, 2016 [23:30] BST Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis
More informationThe Mediterranean Diet: The Optimal Diet for Cardiovascular Health
The Mediterranean Diet: The Optimal Diet for Cardiovascular Health Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health Cardiovascular Disease Prevention International
More informationOverview. The Mediterranean Diet: The Optimal Diet for Cardiovascular Health. No conflicts of interest or disclosures
The Mediterranean Diet: The Optimal Diet for Cardiovascular Health No conflicts of interest or disclosures Vasanti Malik, ScD Research Scientist Department of Nutrition Harvard School of Public Health
More informationKnow Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up
Know Your Number Aggregate Report Comparison Analysis Between Baseline & Follow-up... Study Population: 340... Total Population: 500... Time Window of Baseline: 09/01/13 to 12/20/13... Time Window of Follow-up:
More informationDM type. Diagnostic method of DR. fluorescein angiography; Ophthalmoscopy. ophthalmoscopic examination. fundus photography; Ophthalmoscopy
2012 Informa USA, Inc. DOI: 10.3109/13816810.2012.675398 Online supplementary material published in conjunction with S. Zhao et al.., Nitric oxide synthase 3 (NOS3) 4b/a, T-786C and G894T polymorphisms
More informationA European model for the Automatic Production of Standardized Performance Indicators: the BIRO statistical engine
EUropean Best Information through Regional Outcomes in Diabetes A European model for the Automatic Production of Standardized Performance Indicators: the BIRO statistical engine Fabrizio Carinci Serectrix
More information(n=6279). Continuous variables are reported as mean with 95% confidence interval and T1 T2 T3. Number of subjects
Table 1. Distribution of baseline characteristics across tertiles of OPG adjusted for age and sex (n=6279). Continuous variables are reported as mean with 95% confidence interval and categorical values
More informationPrimary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts
Original Article Primary Prevention of Cardiovascular Disease with a Mediterranean Diet Supplemented with Extra-Virgin Olive Oil or Nuts R. Estruch, E. Ros, J. Salas Salvadó, M.-I. Covas, D. Corella, F.
More informationSupplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms
Supplementary table 1 Demographic and clinical characteristics of participants by paraoxonase-1 (PON-1) gene polymorphisms QQ QR/RR n = 36 n = 80 Men (%) 20 (55) 54 (67) 0.216 Age (years) 57 ± 10 56 ±
More informationInterestinhowmicroRNAscanbeusedinthepreventionand treatment of cardiovascular disease (CVD) 4 has increased over
MicroRNA-410 regulated lipoprotein lipase variant rs13702 is associated with stroke incidence and modulated by diet in the randomized controlled PREDIMED trial 1 3 Dolores Corella, Jose V Sorlí, Ramon
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationYour health is a crucial aspect of your life. That s why the Yakima Heart Center offers this booklet; to help you identify the numbers that affect
Your health is a crucial aspect of your life. That s why the Yakima Heart Center offers this booklet; to help you identify the numbers that affect your health and well-being. Knowing your medical history
More informationWelch Allyn ABPM 6100S. Comprehensive blood pressure monitoring that brings patient comfort home.
Welch Allyn ABPM 6100S Comprehensive blood pressure monitoring that brings patient comfort home. Features and Benefits of the Welch Allyn ABPM 6100S Pictorial application instructions, artery markers and
More informationBLOODPRESSURE & PULSE App for iphone, ipad and ipod USER GUIDE. App Version 2.2
App for iphone, ipad and ipod USER GUIDE App Version 2.2 Table of contents Description 3-4 Views 5 Enter your measurements 6 Summary of your values 7 Stages of Hypertension 8 Statistics 9-10 Diary Logs
More informationDC , Revision 2. Overall Diet History and Reversibility of the Metabolic Syndrome Over 5 Years: The Whitehall II Prospective Cohort Study
May 2010 DC09-2200, Revision 2 Overall Diet History and Reversibility of the Metabolic Syndrome Over 5 Years: The Whitehall II Prospective Cohort Study Running Title: Overall Diet and Reversion of Metabolic
More informationMediterranean Diet and Cardiovascular Health: Teachings of the PREDIMED Study 1 3
SUPPLEMENT Proceedings of the IUNS 20th Congress of Nutrition Mediterranean Diet and Cardiovascular Health: Teachings of the PREDIMED Study 1 3 Emilio Ros, 4,6 *MiguelA.Martínez-González, 6,7 Ramon Estruch,
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationTo reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees.
E Nancy A. Haller, MPH, CHES, Manager, State Wellness Program M PLOYEES To reduce the risk of cardiovascular disease and diabetes among Oklahoma state employees. To suspend or decrease the rising costs
More informationPrevention of Diabetes With Mediterranean Diets A Subgroup Analysis of a Randomized Trial
Annals of Internal Medicine Original Research Prevention of Diabetes With Mediterranean Diets A Subgroup Analysis of a Randomized Trial Jordi Salas-Salvadó, MD, PhD*; Mònica Bulló, PhD; Ramón Estruch,
More informationQualification Form Instructions
Qualification Form Instructions Congratulations on taking steps toward maintaining or improving your health! The Blue Cross Blue Shield of Michigan qualification form is enclosed for you and your physician
More informationSerum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic
Supplementary Information The title of the manuscript Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke Xin-Wei He 1, Wei-Ling Li 1, Cai Li
More informationPage 1. Disclosures. Background. No disclosures
Population-Based Lipid Screening in the Era of a Childhood Obesity Epidemic: The Importance of Non-HDL Cholesterol Assessment Brian W. McCrindle, Cedric Manlhiot, Don Gibson, Nita Chahal, Helen Wong, Karen
More informationThe Clinical Information Data Entry Screen is the main screen in the DQCMS application.
DATA ENTRY Clinical Information The Clinical Information Data Entry Screen is the main screen in the DQCMS application. To enter data, a patient must first be selected from the Patient pull-down list.
More informationFrequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial
Guasch-Ferré et al. BMC Medicine 2013, 11:164 RESEARCH ARTICLE Open Access Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial Marta Guasch-Ferré 1,2, Mònica Bulló
More informationSUPPLEMENTARY MATERIAL
SUPPLEMENTARY MATERIAL The effect of current dietary provided by frequent advice versus food delivery on weight loss and cardiovascular risk factors. A Randomized Clinical Trial. David JA Jenkins, Beatrice
More informationUniversity of Groningen. Metabolic risk in people with psychotic disorders Bruins, Jojanneke
University of Groningen Metabolic risk in people with psychotic disorders Bruins, Jojanneke IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
More informationMetabolic Syndrome Update The Metabolic Syndrome: Overview. Global Cardiometabolic Risk
Metabolic Syndrome Update 21 Marc Cornier, M.D. Associate Professor of Medicine Division of Endocrinology, Metabolism & Diabetes University of Colorado Denver Denver Health Medical Center The Metabolic
More informationQualification Form Instructions
Qualification Form Instructions Congratulations on taking steps toward maintaining or improving your health! The Blue Cross Blue Shield of Michigan Qualification Form is enclosed for you and your physician
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationThe Mediterranean Diet decreases LDL atherogenicity in high cardiovascular risk
The Mediterranean Diet decreases LDL atherogenicity in high cardiovascular risk individuals: a randomized controlled trial Álvaro Hernáez 1,2,3, Olga Castañer 1,3, Alberto Goday 1,3, Emilio Ros 3,4, Xavier
More informationORIGINAL INVESTIGATION. Effect of a Mediterranean Diet Supplemented With Nuts on Metabolic Syndrome Status
ORIGINAL INVESTIGATION Effect of a Mediterranean Diet Supplemented With Nuts on Metabolic Syndrome Status One-Year Results of the PREDIMED Randomized Trial Jordi Salas-Salvadó, MD, PhD; Joan Fernández-Ballart,
More informationRELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES. Yuan Gu
RELATIONSHIP OF CLINICAL FACTORS WITH ADIPONECTIN AND LEPTIN IN CHILDREN WITH NEWLY DIAGNOSED TYPE 1 DIABETES by Yuan Gu BE, Nanjing Institute of Technology, China, 2006 ME, University of Shanghai for
More informationCARE PATHWAYS. Allyson Ashley
CARE PATHWAYS Allyson Ashley WHAT IS A CARE PATHWAY? An explicit statement of the goals and key elements of care based on evidence, best practice, and patient s expectations and their characteristics The
More information2/11/2017. Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox. Disclosures. Carl J. Lavie, MD, FACC, FACP, FCCP
Weighing the Heavy Cardiovascular Burden of Obesity and the Obesity Paradox Carl J. Lavie, MD, FACC, FACP, FCCP Professor of Medicine Medical Director, Cardiac Rehabilitation and Preventive Cardiology
More informationMississippi Stroke Systems of Care
Stroke Initiatives Mississippi State Department of Health Cassandra Dove, Chronic Disease Bureau 19 th Annual Stroke Belt Consortium March 1, 2014 Mississippi Stroke Systems of Care Heart Disease and Stroke
More informationDietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease 1
Dietary fat intake and risk of cardiovascular disease and all-cause mortality in a population at high risk of cardiovascular disease 1 Marta Guasch-Ferré, 2,3 Nancy Babio, 2,3 Miguel A Martínez-González,
More informationPrimary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group
Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to
More informationModule 2. Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension
Module 2 Global Cardiovascular Risk Assessment and Reduction in Women with Hypertension 1 Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored,
More informationCase Discussions: Treatment Strategies for High Risk Populations. Most Common Reasons for Referral to the Baylor Lipid Clinic
Case Discussions: Treatment Strategies for High Risk Populations Peter H. Jones MD, FNLA Associate Professor Methodist DeBakey Heart and Vascular Center Baylor College of Medicine Most Common Reasons for
More informationCardiovascular Disease Risk Behaviors of Nursing Students in Nursing School
International Journal of Medical Research & Health Sciences Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2018, 7(8): 16-33 I J M R
More informationDyslipidemia: Lots of Good Evidence, Less Good Interpretation.
Dyslipidemia: Lots of Good Evidence, Less Good Interpretation. G Michael Allan Evidence & CPD Program, ACFP Associate Professor, Dept of Family, U of A. CFPC CoI Templates: Slide 1 Faculty/Presenter Disclosure
More informationNational Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register
National Collaborative Wave 2 (Wave 9): National Diabetes Prevention and Management Wave, Month 9 Diabetes Management: Diabetes Register The above graph shows a decrease in the number of patients on the
More informationReduction in the Incidence of Type 2-Diabetes with the Mediterranean Diet: Results of the PREDIMED-Reus Nutrition Intervention Randomized Trial
Diabetes Care Publish Ahead of Print, published online October 13, 2010 Reduction in the Incidence of Type 2-Diabetes with the Mediterranean Diet: Results of the PREDIMED-Reus Nutrition Intervention Randomized
More informationScreening Results. Juniata College. Juniata College. Screening Results. October 11, October 12, 2016
Juniata College Screening Results Juniata College Screening Results October 11, 2016 & October 12, 2016 JUNIATA COLLEGE The J.C. Blair Hospital CARES team screened 55 Juniata College employees on October
More informationMediterranean diet, retinopathy and nephropathy microvascular diabetes complications:
Mediterranean diet, retinopathy and nephropathy microvascular diabetes complications: A post hoc analysis of a randomized trial Andrés Díaz-López, RD 1,2 ; Nancy Babio, BSc, PhD 1,2 ; Miguel A Martínez-González,
More informationMediterranean Diet Pattern and Health
NUTRI-BITES Webinar Series Mediterranean Diet Pattern and Health will begin at the top of the hour Audio for today s presentation is being broadcast over your computer speakers, so be sure they are turned
More informationAndrejs Kalvelis 1, MD, PhD, Inga Stukena 2, MD, Guntis Bahs 3 MD, PhD & Aivars Lejnieks 4, MD, PhD ABSTRACT INTRODUCTION. Riga Stradins University
CARDIOVASCULAR RISK FACTORS ORIGINAL ARTICLE Do We Correctly Assess the Risk of Cardiovascular Disease? Characteristics of Risk Factors for Cardiovascular Disease Depending on the Sex and Age of Patients
More informationSupplemental Table 1 Age and gender-specific cut-points used for MHO.
Supplemental Table 1 Age and gender-specific cut-points used for MHO. Age SBP (mmhg) DBP (mmhg) HDL-C (mmol/l) TG (mmol/l) FG (mmol/l) Boys 6-11 90th * 90th * 1.03 1.24 5.6 12 121 76 1.13 1.44 5.6 13 123
More informationThe increasing incidence of type 2 diabetes
Clinical Care/Education/Nutrition/Psychosocial Research O R I G I N A L A R T I C L E Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet Results of the PREDIMED-Reus nutrition intervention
More informationNutrition Care Process. Catherine Villafranca & Anthony Richitt
Nutrition Care Process Catherine Villafranca & Anthony Richitt Nutrition Care Process -According to eatrightpro.org, the Nutrition Care Process is a systematic approach to providing high-quality nutrition
More informationInflammation and and Heart Heart Disease in Women Inflammation and Heart Disease
Inflammation and Heart Disease in Women Inflammation and Heart Disease What is the link between een inflammation and atherosclerotic disease? What is the role of biomarkers in predicting cardiovascular
More informationMediterranean Diet and Cardiodiabesity: A Review
Nutrients 2014, 6, 3474-3500; doi:10.3390/nu6093474 Review OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Mediterranean Diet and Cardiodiabesity: A Review Elena García-Fernández 1,2,
More informationPredictors of short- and long-term adherence with a Mediterranean-type diet intervention: the PREDIMED randomized trial
Downer et al. International Journal of Behavioral Nutrition and Physical Activity (2016) 13:67 DOI 10.1186/s12966-016-0394-6 RESEARCH Open Access Predictors of short- and long-term adherence with a Mediterranean-type
More informationSUPPLEMENTAL MATERIAL. Materials and Methods. Study design
SUPPLEMENTAL MATERIAL Materials and Methods Study design The ELSA-Brasil design and concepts have been detailed elsewhere 1. The ELSA-Brasil is a cohort study of active or retired 15,105 civil servants,
More informationOverweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes
Overweight and Obesity in Older Persons: Impact Upon Health and Mortality Outcomes Gordon L Jensen, MD, PhD Senior Associate Dean for Research Professor of Medicine and Nutrition Objectives Health outcomes
More informationSupplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups
Supplemental Table S1: Unadjusted and Adjusted Hazard Ratios for Diabetes Associated with Baseline Factors Considered in Model 3 SMART Participants Only Unadjusted Adjusted* Baseline p-value p-value Covariate
More informationCorrelation of novel cardiac marker
Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely
More informationThe Metabolic Syndrome: Is It A Valid Concept? YES
The Metabolic Syndrome: Is It A Valid Concept? YES Congress on Diabetes and Cardiometabolic Health Boston, MA April 23, 2013 Edward S Horton, MD Joslin Diabetes Center Harvard Medical School Boston, MA
More informationMetabolic Syndrome.
www.bmiweightloss.com.au What is the metabolic syndrome? The was first described in 1988 by Gerald Reavson It was originally described as the clustering of four conditions These conditions when present
More informationInformation Management in General Practice
Information Management in General Practice Using PEN Clinical Audit Tool Training Workbook for General Practice Written by Noel Stewart March 2010 Workbook and Training Course for General Practice Acknowledgments:
More informationObjectives. Objectives. Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015
Alejandro J. de la Torre, MD Cook Children s Hospital May 30, 2015 Presentation downloaded from http://ce.unthsc.edu Objectives Understand that the obesity epidemic is also affecting children and adolescents
More informationProfessor Clare Collins
Dietary Patterns and Cardiovascular Disease (CVD) Outcomes: An evidence summary Professor Clare Collins PhD, BSc, Dip Nutr&Diet, Dip Clin Epi, advapd, FDAA Director of Research, School of Health Sciences,
More informationMethods. Background and Objectives STRADIVARIUS
STRADIVARIUS Effect of on Progression of Atherosclerosis in Patients with Abdominal Obesity and Coronary Artery Disease Steven E. Nissen MD Stephen J. Nicholls MBBS PhD, Kathy Wolski MPH, Josep Rodés-Cabau
More informationHeart Health. Team Member Workbook Session 1 LEARN IDENTIFY ACT. Learn about HTHU Level 3 and the point system
LEARN Learn about HTHU Level 3 and the point system 01 IDENTIFY Identify the major risk factors for cardiovascular disease and how to improve our cardiovascular health 03 02 ACT Begin our Session 1 Goal
More informationPIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia
PIEDMONT ACCESS TO HEALTH SERVICES, INC. Policy Number: 01-09-021 SUBJECT: Guidelines for Screening and Management of Dyslipidemia EFFECTIVE DATE: 04/2008 REVIEWED/REVISED: 04/12/10, 03/17/2011, 4/10/2012,
More informationPositive Change for Life
Positive Change for Life Dr Sharon Avery, Project lead on behalf of the Alfred Late Effects Clinic, on behalf of the Alfred Late Effects Clinic, Leukaemia Foundation and Southern Melbourne Integrated Cancer
More informationASSeSSing the risk of fatal cardiovascular disease
ASSeSSing the risk of fatal cardiovascular disease «Systematic Cerebrovascular and coronary Risk Evaluation» think total vascular risk Assess the risk Set the targets Act to get to goal revised; aupril
More informationRisk Factors for Heart Disease
Risk Factors for Heart Disease Risk Factors we cannot change (Age, Gender, Family History) Risk Factors we can change (modifiable) Smoking Blood pressure Cholesterol Diabetes Inactivity Overweight Stress
More informationDirector, Employee Health & Productivity. Coordinator, Employee Health & Productivity
Director, Employee Health & Productivity Coordinator, Employee Health & Productivity Table 2:. ChartE: Female HDL Cholesterol Risk Levels Optimal Borderline High Risk 80% 60% 40% 20% 0% LDL Cholesterol
More informationWhy are NICE guidelines and standards important and relevant to us?
Why are NICE guidelines and standards important and relevant to us? Dr Liz England GP, Laurie Pike health centre RCGP Mental Health Clinical and Commissioning Lead SWB CCG Mental Health Lead NIHR Clinical
More informationStatin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography
Statin therapy in patients with Mild to Moderate Coronary Stenosis by 64-slice Multidetector Coronary Computed Tomography Hyo Eun Park 1, Eun-Ju Chun 2, Sang-Il Choi 2, Soyeon Ahn 2, Hyung-Kwan Kim 3,
More informationWhy Screen at 23? What can YOU do?
Why Screen at 23? Every 1 in 2 Asian American adults has diabetes or prediabetes. More than half of Asian Americans did not know they have type 2 diabetes or prediabetes. Asian Americans can develop diabetes
More informationMediterranean Diet: Miracle or Mirage. Edwin Cox, M.D.
Mediterranean Diet: Miracle or Mirage Edwin Cox, M.D. The Mediterranean Diet Unique Distinction The only major diet whose effectiveness has been demonstrated in controlled trials In subjects with a first
More informationSUPPLEMENTAL MATERIAL
SUPPLEMENTAL MATERIAL Supplemental Table 1. Distribution of Participants Characteristics by Treatment Group at Baseline - The Vitamin D and calcium (CaD) Trial of the Women s Health Initiative (WHI) Study,
More informationMOLINA HEALTHCARE OF CALIFORNIA
MOLINA HEALTHCARE OF CALIFORNIA HIGH BLOOD CHOLESTEROL IN ADULTS GUIDELINE Molina Healthcare of California has adopted the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel
More informationIntro to R. Professor Clayton Nall h/t Thomas Leeper, Ph.D. (University of Aarhus) and Teppei Yamamoto, Ph.D. (MIT) June 26, 2014
Intro to R Professor Clayton Nall h/t Thomas Leeper, Ph.D. (University of Aarhus) and Teppei Yamamoto, Ph.D. (MIT) June 26, 2014 Nall Intro to R 1 / 44 Nall Intro to R 2 / 44 1 Opportunities 2 Challenges
More informationLEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME
LEPTIN AS A NOVEL PREDICTOR OF DEPRESSION IN PATIENTS WITH THE METABOLIC SYNDROME Diana A. Chirinos, Ronald Goldberg, Elias Querales-Mago, Miriam Gutt, Judith R. McCalla, Marc Gellman and Neil Schneiderman
More informationfor the Management of Chronic Disease
Patient-Centred Care Approaches for the Management of Chronic Disease Anna Chapman Research Fellow RDNS Institute Overview of Presentation Burden Second of level Disease in Australia Chronic Disease Management
More informationClient Report Screening Program Results For: Missouri Western State University October 28, 2013
Client Report For: Missouri Western State University October 28, 2013 Executive Summary PROGRAM OVERVIEW From 1/1/2013-9/30/2013, Missouri Western State University participants participated in a screening
More informationSupplementary Online Content
Supplementary Online Content McEvoy JW, Chen Y, Ndumele CE, et al. Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol.
More informationHealth First. New Health Bucks Program MANATEE YOURCHOICE HEALTH PLAN
Health First New Health Bucks Program MANATEE YOURCHOICE HEALTH PLAN www.manateeyourchoice.com/healthfirst A special thanks to Aetna for covering the printing costs of this booklet. CONTENTS OUR PURPOSE
More informationUnderstanding the metabolic syndrome
Understanding the metabolic syndrome Understanding the metabolic system Metabolic syndrome is the clustering together of a number of risk factors for heart disease, stroke and diabetes. Having one of these
More informationAuthor, year Study Location Outcome(s) Exposure n Follow-up Results/observations. MedDiet rich in alpha-linolenic diet vs usual post-infarct prudent
SUPPLEMENTAL MATERIAL Table 3. Main prospective observational studies and randomized controlled trials published until May 2017, assessing the effects of the Mediterranean diet on from or incidence of
More informationBiases in clinical research. Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University
Biases in clinical research Seungho Ryu, MD, PhD Kanguk Samsung Hospital, Sungkyunkwan University Learning objectives Describe the threats to causal inferences in clinical studies Understand the role of
More informationThe Mediterranean Diet improves HDL function in high cardiovascular risk
The Mediterranean Diet improves HDL function in high cardiovascular risk individuals: a randomized controlled trial Álvaro Hernáez, PharmD, MSc 1,2,3 ; Olga Castañer, MD, PhD 1,3 ; Roberto Elosua, MD,
More informationSupplementary Online Content
Supplementary Online Content Larsen JR, Vedtofte L, Jakobsen MSL, et al. Effect of liraglutide treatment on prediabetes and overweight or obesity in clozapine- or olanzapine-treated patients with schizophrenia
More informationLetter to the Editor. Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes *
814 Biomed Environ Sci, 2016; 29(11): 814-817 Letter to the Editor Association of TCF7L2 and GCG Gene Variants with Insulin Secretion, Insulin Resistance, and Obesity in New-onset Diabetes * ZHANG Lu 1,^,
More informationMediterranean diet score and total and cardiovascular mortality in Eastern Europe: the HAPIEE study
DOI 10.1007/s00394-015-1092-x ORIGINAL CONTRIBUTION Mediterranean diet score and total and cardiovascular mortality in Eastern Europe: the HAPIEE study Denes Stefler 1 Sofia Malyutina 2 Ruzena Kubinova
More informationIs Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea
Is Knowing Half the Battle? Behavioral Responses to Risk Information from the National Health Screening Program in Korea Hyuncheol Bryant Kim 1, Suejin A. Lee 1, and Wilfredo Lim 2 1 Cornell University
More informationEffective Interventions in the Clinical Setting: Engaging and Empowering Patients. Michael J. Bloch, M.D. Doina Kulick, M.D.
Effective Interventions in the Clinical Setting: Engaging and Empowering Patients Michael J. Bloch, M.D. Doina Kulick, M.D. UNIVERSITY OF NEVADA SCHOOL of MEDICINE Sept. 8, 2011 Reality check: What could
More information